In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment ...

Medically reviewed by Robert Burakoff, MD Celiac disease is a chronic autoimmune disorder that can damage the lining of your ...

Osteoporosis, a disease that weakens your bones, is also called a “silent” disease because there are no warning signs until a ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

Lung transplant patients should undergo annual bone health screenings using dual-energy X-ray absorptiometry for the first ...

An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...

The presentation highlights the potential benefits of eneboparatide as a treatment for hypoparathyroidism, an illness in ...

Calcium levels decreased less with each subsequent denosumab dose among individuals with osteoporosis and advanced chronic kidney disease.

And every time I walk down the street or get on a bus I worry that people are judging me for how I look. Since starting ...

FRAX has been validated for fracture risk assessment for patients with cancer, with HRs indicating an association between ...

Entera Bio ( (ENTX) ) just unveiled an announcement. Entera Bio Ltd., a leader in oral peptide development, reported Q3 2024 financial results ...